Affinity Asset Advisors »

Omeros Corp shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Omeros Corp shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Omeros Corp

Tip: Access up to 7 years of quarterly data

All positions including Omeros Corp held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Omeros Corp by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.6M 11M 0.73
2023-12-31 $3.6M 6.0M 0.60

More positions owned by Affinity Asset Advisors

Spdr Ser Tr S&p Biotech Put Option (XBI)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Moderna Put Option (MRNA)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Autolus Therapeutics Spon Ads (AUTL)
Celldex Therapeutics Com New (CLDX)
Arcellx Common Stock (ACLX)
Vera Therapeutics Cl A (VERA)
Inozyme Pharma (INZY)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Kura Oncology (KURA)
Spyre Therapeutics Com New (SYRE)

View all positions for Affinity Asset Advisors

Top funds holding Omeros Corp

Athyrium Capital Management
Highbridge Capital Management
DeepCurrents Investment Group
D. E. Shaw & Co
Whitebox Advisors
Affinity Asset Advisors
Verition Fund Management
Wells Fargo & Company
Capstone Investment Advisors
Sonora Investment Management Group
Agf Management
Ingalls & Snyder
Context Capital Management
Bank of America Corporation
Planning Capital Management Corp

View all funds holding Omeros Corp